Web Exclusives

New Posttreatment Guidelines for Gynecologic Cancers Developed

Clinical observations are more effective than routine testing in posttreatment surveillance and diagnosis of most gynecologic tumors

Prolonged Use of Diabetes Drug Actos May Increase Risk of Bladder Cancer

The FDA announced that the prolonged use of pioglitazone (Actos) for more than 1 year has been linked to an increased risk of bladder cancer

New Genetic Test Aids Detection of HER2+ Breast Cancer

On Tuesday the FDA approved a genetic test known as Inform Dual ISH that detects HER2+ breast cancer

Scientists Pioneer Technology to Detect More Chromosomal Aberrations in Cancer Tumors

The investigators developed a computer tool that is dramatically better for finding genetic missteps that promote cancer.

World Community Responds to the Global Cancer Crisis

According to the World Health Organization, NCDs, such as cancer, comprise 63% of annual global mortalities, claiming the lives of 7.6 million people each year

Socioeconomic Status Bears Little Impact on Survival Rates

Primary cancers of the lung, esophagus, and pancreas-all of which have a poor prognosis-account for >35% of all cancer deaths in the United States annually

Experimental Melanoma Vaccine May Shrink Late-Stage Tumors

An experimental melanoma vaccine gp100 peptide vaccine in combination with IL2 may shrink tumors and prevent the progression of late-stage melanoma

Vemurafenib Leads the Pack in new Melanoma Drugs, Research to be Presented at ASCO

Melanoma is now being treated with drugs and new treatment regimes that have shown great promise

Abiraterone Acetate Improves Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

Men with advanced CRPC who were treated with abiraterone acetate plus prednisone/prednisolone had significant improvement in overall survival

FDA Approves Sutent for Pancreatic Cancer

The FDA has approved Sutent (sunitinib) for the treatment of patients with unresectable, locally advanced, or metastatic pancreatic neuroendocrine tumors (pNET)

9

Bringing the Oncology Community Together

Web Exclusives